Debt and Lines of Credit - Narrative (Details) € in Millions, ¥ in Millions, $ in Millions								1 Months Ended
	Nov. 19, 2024 USD ($)	Nov. 19, 2024 EUR (€)	Jun. 26, 2024 USD ($)	Jan. 29, 2024 USD ($)	Nov. 30, 2023 USD ($)	Sep. 27, 2023 USD ($)	Sep. 27, 2023 EUR (€)	Sep. 30, 2023 USD ($)	Dec. 31, 2024 USD ($)	Jun. 26, 2024 JPY (¥)	Jun. 25, 2024 JPY (¥)	Dec. 31, 2023 USD ($)
Debt Instrument [Line Items]
Total long-term debt									$ 14,125			$ 14,679
Principal payments required, year one									1,500
Principal payments required, year two									2,900
Principal payments required, year three									617
Principal payments required, year four									650
Principal payments required, year five									583
Principal payments required, after year five									$ 8,000
Bigfoot Biomedical
Debt Instrument [Line Items]
Repayments of debt								$ 197
0.10% Notes, due 2024
Debt Instrument [Line Items]
Repayments of debt	$ 640	€ 590
Interest rate percentage	0.10%	0.10%
3.40% Notes, due 2023
Debt Instrument [Line Items]
Repayments of debt					$ 1,050
Interest rate percentage									3.40%
0.875% Notes, due 2023
Debt Instrument [Line Items]
Repayments of debt						$ 1,200	€ 1,140
Interest rate percentage									0.875%
2029 Five Year Credit Agreement | Revolving Credit Facility
Debt Instrument [Line Items]
Maturity period			5 years	5 years
Maximum borrowing capacity									$ 5,000	¥ 92,000	¥ 59,800
Proceeds from long term lines of credit			$ 201
2020 Five Year Credit Agreement | Line of Credit
Debt Instrument [Line Items]
Maturity period				5 years
Total long-term debt				$ 0